期刊文献+

When important steps for a reliable Meta-analysis are missing: the bevacizumab versus ranibizumab case

When important steps for a reliable Meta-analysis are missing: the bevacizumab versus ranibizumab case
下载PDF
导出
摘要 【正】Dear Sir,W e have read with attention and interest the systematic review on the effectiveness and safety of bevacizumab and ranibizumab in the treatment of age-related macular degeneration(AMD)written by Zhang et al[1]and published on number of April 2014 of International Journal of Ophthalmology.The authors,who collected data from 4randomized clinical trials(RCTs)and 11 observational <正>Dear Sir,W e have read with attention and interest the systematic review on the effectiveness and safety of bevacizumab and ranibizumab in the treatment of age-related macular degeneration(AMD)written by Zhang et al[1]and published on number of April 2014 of International Journal of Ophthalmology.The authors,who collected data from 4randomized clinical trials(RCTs)and 11 observational
出处 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2015年第1期204-205,共2页 国际眼科杂志(英文版)
  • 相关文献

参考文献7

  • 1Usha Chakravarthy,Simon P Harding,Chris A Rogers,Susan M Downes,Andrew J Lotery,Lucy A Culliford,Barnaby C Reeves.Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial[J]. The Lancet . 2013
  • 2Laurent Kodjikian,Eric H. Souied,Gérard Mimoun,Martine Mauget-Fa?sse,Francine Behar-Cohen,Evelyne Decullier,Laure Huot,Gilles Aulagner.Ranibizumab versus Bevacizumab for neovascular age-related macular degeneration. Results from the GEFAL noninferiority randomized trial[J]. Ophthalmology . 2013
  • 3Daniel F. Martin,Maureen G. Maguire,Stuart L. Fine,Gui-shuang Ying,Glenn J. Jaffe,Juan E. Grunwald,Cynthia Toth,Maryann Redford,Frederick L. Ferris.Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration[J]. Ophthalmology . 2012 (7)
  • 4Usha Chakravarthy,Simon P. Harding,Chris A. Rogers,Susan M. Downes,Andrew J. Lotery,Sarah Wordsworth,Barnaby C. Reeves.Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration[J]. Ophthalmology . 2012 (7)
  • 5Sanjay Sharma,Davin Johnson,Marwan Abouammoh,Simon Hollands,Ashley Brissette.Rate of serious adverse effects in a series of bevacizumab and ranibizumab injections[J]. Canadian Journal of Ophthalmology/Journal canadien d’ophtalmologie . 2012 (3)
  • 6Ilse Krebs,Leopold Schmetterer,Agnes Boltz,Reinhard Told,Veronika Vécsei-Marlovits,Stefan Egger,Ulrich Sch?nherr,Anton Haas,Siamak Ansari-Shahrezaei,Susanne Binder,for the MANTA Research Group.A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration. British Journal of Ophthalmology . 2013
  • 7Reeves BC,Deeks JJ,Higgins JPT,Wells GA.Including non-randomized studies. Cochrane Handbook for Systematic Reviews of Interventions.Version 5.1.0 . 2011

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部